Assetmark, Inc Jazz Pharmaceuticals PLC Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Assetmark, Inc holds 680 shares of JAZZ stock, worth $84,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares

680

Previous 716 5.03%

Holding current value

$84,136

Previous $76,000 1.32%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.57 - $116.37 $3,620 - $4,189	-36 Reduced 5.03%	680 $75,000
Q2 2024 Aug 13, 2024	BUY	$103.94 - $118.98 $11,121 - $12,730	107 Added 17.57%	716 $76,000
Q1 2024 May 06, 2024	BUY	$115.19 - $132.77 $19,467 - $22,438	169 Added 38.41%	609 $73,000
Q4 2023 Feb 09, 2024	BUY	$114.26 - $136.0 $13,596 - $16,184	119 Added 37.07%	440 $54,000
Q3 2023 Oct 27, 2023	SELL	$122.0 - $145.31 $1,586 - $1,889	-13 Reduced 3.89%	321 $41,000
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $19,232 - $23,104	157 Added 88.7%	334 $41,000
Q1 2023 May 05, 2023	BUY	$133.98 - $160.47 $401 - $481	3 Added 1.72%	177 $25,000
Q4 2022 Feb 10, 2023	SELL	$129.72 - $159.85 $2,075 - $2,557	-16 Reduced 8.42%	174 $27,000
Q3 2022 Nov 01, 2022	BUY	$126.59 - $161.18 $1,645 - $2,095	13 Added 7.34%	190 $25,000
Q2 2022 Aug 03, 2022	SELL	$141.59 - $168.66 $7,362 - $8,770	-52 Reduced 22.71%	177 $28,000
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $8,556 - $10,606	66 Added 40.49%	229 $36,000
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $9.95 Million - $12.1 Million	-82,976 Reduced 99.8%	163 $21,000
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $9.52 Million - $13.7 Million	73,978 Added 807.53%	83,139 $10.8 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $1.47 Million - $1.71 Million	9,161 New	9,161 $1.63 Million
Q2 2020 Aug 11, 2020	SELL	$95.68 - $121.88 $8,324 - $10,603	-87 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$87.74 - $152.74 $175 - $305	2 Added 2.35%	87 $9,000
Q4 2019 Feb 11, 2020	BUY	$117.65 - $153.73 $10,000 - $13,067	85 New	85 $13,000
Q3 2019 Nov 13, 2019	SELL	$125.18 - $143.24 $3,004 - $3,437	-24 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $2,636 - $3,034	21 Added 700.0%	24 $3,000
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $852 - $1,000	-7 Reduced 70.0%	3 $0
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $811 - $1,167	7 Added 233.33%	10 $1,000
Q1 2017 Sep 15, 2017	SELL	N/A	-1 Reduced 25.0%	3 $0
Q4 2016 Sep 15, 2017	SELL	N/A	-225 Reduced 98.25%	4 $0
Q3 2016 Sep 15, 2017	SELL	N/A	-111 Reduced 32.65%	229 $28,000
Q2 2016 Sep 15, 2017	BUY	N/A	217 Added 176.42%	340 $48,000
Q1 2016 Sep 15, 2017	SELL	N/A	-6,403 Reduced 98.12%	123 $16,000
Q4 2015 Sep 15, 2017	BUY	N/A	6,526	6,526 $917,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.76B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account